Risks for ULTRAGENYX PHARMACEUTICAL INC (RARE)

Here are some interesting risks from the recent filings of ULTRAGENYX PHARMACEUTICAL INC. Our algorithms work hard to highlight risks unique to this company.

We have not generated any significant revenue from product sales and we may never be profitable.

We are heavily dependent on the success of our product candidates, some of which are in the early stages of clinical development, which is a lengthy and expensive process with uncer

tain outcomes and the potential for substantial delays. We cannot give any assurance that any of our product candidates will receive regulatory approval, which is necessary before they can be commercialized.

We rely on third parties to manufacture our product and most of our prod

uct candidates. Our business could be harmed if those third parties fail to provide us with sufficient quantities of drug product, or fail to do so at acceptable quality levels or prices.